Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a
persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the …

The global burden of chronic liver disease (CLD) is substantial. Due to the limited indication
of and accessibility to antiviral therapy in viral hepatitis and lack of effective pharmacological …

Preclinical studies highlighted potential therapeutic applications of aspirin and statins as
anticancer agents based on their pleiotropic effects. Epidemiologic studies suggested the …

Methods: We searched for PubMed and EMBASE through September 2021. Results:
Eighteen studies (16 cohort, 2 case-control) were included. Aspirin users were less likely to …

Acetylsalicylic acid (ASA) is one of the most commonly used drugs in the world. It derives
from the extract of white willow bark, whose therapeutic potential was known in Egypt since …

Aim: To explore the relationship between the use of aspirin and the incidence of
hepatocellular carcinoma (HCC). Methods: MEDLINE, EMBASE, Web of Science and …

According to the current research evidence, the therapy of nonsteroidal anti-inflammatory
drugs (NSAIDs) might effectively decrease the risk of hepatocellular carcinoma (HCC) …

Background Previous studies have suggested a chemoprotective effect of aspirin in
hepatocellular carcinoma (HCC), but evidence is limited for patients with chronic liver …

Mass vaccination campaigns against HBV and treatment of chronic HBV carriers with oral
nucleos (t) ide analogues (NUCs) represent the pillars of World Health Organization …

Acetylsalicylic acid (ASA) is one of the most commonly used drugs in the world. It derives
from the extract of white willow bark, whose therapeutic potential was known in Egypt since …